Geriatric DisordersGRIMMNCT03579056
GeRIatric Multidisciplinary Meeting
An observational study of Geriatric Disorders, run by University Hospital, Angers at 1 site in France.
Trial summary
The primary objective of this study is to develop a typology of patients referred to the Geriatric Multidisciplinary Meeting (GMM) according to their demographic and clinical profile. The secondary objectives are: To distinguish the different types of answers given by the GMM according to the demands and situations. Read more about this study
- Who is it for?
- Ages 64 years and older
- Conditions the study is for
- Geriatric Disorders
- How many people
- 734 participants
- Where
- 1 siteFrance
- Study dates
- 16 Feb 2017to 4 Sep 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 64 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients are recruited during the GMM of the University Hospital of Angers, France
Who may be able to join
- All the files discussed in GMM in the year 2015 following a request for geriatric care addressed to the Geriatrics department of the UH
Who cannot join
- No one
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Modeling of the Geriatric Multidisciplinary Meeting of the Angers University Hospital
The primary objective of this study is to develop a typology of patients referred to the Geriatric Multidisciplinary Meeting (GMM) according to their demographic and clinical profile.
The secondary objectives are:
- To distinguish the different types of answers given by the GMM according to the demands and situations.
- To study the factors associated with the orientation proposed by the GMM
- To examine the adequacy between the orientation proposed by the GMM and the pathway actually taken
- To compare the diagnoses made during the following year with the data collected during the GMM
Read the detailed description
Increasing attention is paid to care pathways for elderly according to the principle of good care applied to the right patient at the right time and in the most appropriate care structure.
Since 2007, the geriatric mobile team (GMT) of the Angers University Hospital has formalized a geriatric multidisciplinary meeting (GMM) in connection with the geriatric network and branch of the geographical sector, in order to optimize the provision of care for elderly patients at the territorial level.
The weekly GMM brings together physicians from the geriatric department (GMT, acute care unit), memory center, long-term care and skilled nursing facilities, cognitive behavioral unit, psychiatry, retirement home, the local geriatric network of the city of Angers, the local information and coordination center, the home for autonomy and integration of Alzheimer patients (MAIA) and specialized Alzheimer (ESA) teams. Requests come either University Hospital services or from outside, via a standardized form. If necessary, additional data collection is carried out before the meeting by telephone with the patient, his family or the general practitioner. A letter explaining the decision of the GMM is sent to the applicant physician and to the general practitioner and recorded in the patient file.
Collegial guidance decisions within the health care system seem to follow implicit rules. Given the growing number of files presented, the investigators want to theorize the adopted mode of reflection.
- Conditions
- Geriatric Disorders
What is being measured
The primary outcome is the main question the study is designed to answer.
The demographic characteristics and medico-social data provided by the physician and the family at the time of the consultation request
The demographic characteristics are age, sex, marital status, place of life, career, presence of un/formal assistance, …
Measured: baseline
Secondary outcomes (4)
The answer given by the GMM
This outcome is assessed by the guidance proposal issued by GMM
Measured: baseline
The orientation proposed by the GMM
The recommendations made by GMM
Measured: baseline
The adequacy between the orientation proposed by the GMM and the pathway actually taken : back in the previous structure, hospitalization, reorientation, entry to a nursing home, other :
The course of care carried out at the Angers UH after the GMM
Measured: baseline and during the following year
The diagnoses made during the following year with the data collected during the GMM : Alzheimer's disease, mixed dementia, body lewy, Parkinson's disease, frontotemporal dementia, vascular dementia, other
Diagnoses carried out at the Angers UH after the GMM
Measured: baseline and during the following year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Jul 2018
- Study start16 Feb 2017
- Primary completion4 Sep 2017
- Study completion4 Sep 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Geriatric DisordersStudies of the same condition, open and under way.
- More trials run by University Hospital, AngersThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 734 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Angers
- Sponsor type
- Other government
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03579056
- Sponsor's protocol ID
- 2017-06
- Acronym
- GRIMM
- Status last verified
- Oct 2017
- First submitted
- 26 Oct 2017
- Last updated
- 6 Jul 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Jul 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Modeling of the Geriatric Multidisciplinary Meeting of the Angers University Hospital
- ClinicalTrials.gov ID
- NCT03579056
- Acronym / sponsor ID
- GRIMM / 2017-06
- Conditions
- Geriatric Disorders
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 734 participants (actual)
- Lead sponsor
- University Hospital, AngersOther government
- Study start
- 16 Feb 2017 (actual)
- Primary completion
- 4 Sep 2017 (actual)
- Study completion
- 4 Sep 2017 (actual)
- First posted
- 6 Jul 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary objective of this study is to develop a typology of patients referred to the Geriatric Multidisciplinary Meeting (GMM) according to their demographic and clinical profile.
The secondary objectives are:
- To distinguish the different types of answers given by the GMM according to the demands and situations.
- To study the factors associated with the orientation proposed by the GMM
- To examine the adequacy between the orientation proposed by the GMM and the pathway actually taken
- To compare the diagnoses made during the following year with the data collected during the GMM
Detailed description
Increasing attention is paid to care pathways for elderly according to the principle of good care applied to the right patient at the right time and in the most appropriate care structure.
Since 2007, the geriatric mobile team (GMT) of the Angers University Hospital has formalized a geriatric multidisciplinary meeting (GMM) in connection with the geriatric network and branch of the geographical sector, in order to optimize the provision of care for elderly patients at the territorial level.
The weekly GMM brings together physicians from the geriatric department (GMT, acute care unit), memory center, long-term care and skilled nursing facilities, cognitive behavioral unit, psychiatry, retirement home, the local geriatric network of the city of Angers, the local information and coordination center, the home for autonomy and integration of Alzheimer patients (MAIA) and specialized Alzheimer (ESA) teams. Requests come either University Hospital services or from outside, via a standardized form. If necessary, additional data collection is carried out before the meeting by telephone with the patient, his family or the general practitioner. A letter explaining the decision of the GMM is sent to the applicant physician and to the general practitioner and recorded in the patient file.
Collegial guidance decisions within the health care system seem to follow implicit rules. Given the growing number of files presented, the investigators want to theorize the adopted mode of reflection.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 64 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients are recruited during the GMM of the University Hospital of Angers, France
Key inclusion criteria (1 listed)
- All the files discussed in GMM in the year 2015 following a request for geriatric care addressed to the Geriatrics department of the UH
Key exclusion criteria (1 listed)
- No one
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
The demographic characteristics and medico-social data provided by the physician and the family at the time of the consultation request
Time frame: baseline
The demographic characteristics are age, sex, marital status, place of life, career, presence of un/formal assistance, …
4 secondary outcomes
The answer given by the GMM
Time frame: baseline
The orientation proposed by the GMM
Time frame: baseline
The adequacy between the orientation proposed by the GMM and the pathway actually taken : back in the previous structure, hospitalization, reorientation, entry to a nursing home, other :
Time frame: baseline and during the following year
The diagnoses made during the following year with the data collected during the GMM : Alzheimer's disease, mixed dementia, body lewy, Parkinson's disease, frontotemporal dementia, vascular dementia, other
Time frame: baseline and during the following year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Jul 2018.
Related trials for Geriatric Disorders
RecruitingPhase 4
Efficacy and Safety of Polatuzumab Vedotin, Rituximab Combined With Reduced-dose Cyclophosphamide, Doxorubicin and Prednisone Regimen in the Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma: A Multicenter, Single-arm, Prospective Study
Diffuse Large B-Cell Lymphoma
Active, not recruitingObservational study
Feasibility of Vision-Language Models for Detecting Physical Assistance as an Observable Criterion Defining GMFCS Levels in Children Aged 2 to 6 Years With Cerebral Palsy
Cerebral Palsy
Not yet recruitingPhase 3
A Study to Evaluate Efficacy, Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older
Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus (RSV) Infection
Not yet recruiting
The Effectiveness of a Caregiver-Based Multicomponent Intervention to Prevent Pressure Ulcers in Home-Cared-For Individuals With Dementia
Dementia, Home Care for Elderly or Disabled Individuals
RecruitingPhase 2/3
A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe Disease
RSV
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Geriatric Disorders, run by University Hospital, Angers at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The demographic characteristics and medico-social data provided by the physician and the family at the time of the consultation request (time frame: baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2018.